Lazard Asset Management
KIDS icon

Lazard Asset Management’s OrthoPediatrics KIDS Stock Holding History

Lazard Asset Management’s Portfolio KIDS Stock Details KIDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,127
Closed -$84K – 2430
2022
Q4 		$84K Hold
2,127
– – ﹤0.01% 1592
2022
Q3 		$98K Hold
2,127
– – ﹤0.01% 1485
2022
Q2 		$91K Buy
2,127
+918
+76% +$42K ﹤0.01% 1543
2022
Q1 		$65K Buy
+1,209
New +$61.8K ﹤0.01% 1613
2020
Q2 		– Sell
-1,426
Closed -$56K – 1702
2020
Q1 		$56K Buy
1,426
+793
+125% +$35.5K ﹤0.01% 1140
2019
Q4 		$29K Buy
633
+282
+80% +$10.9K ﹤0.01% 1160
2019
Q3 		$12K Buy
+351
New +$12.2K ﹤0.01% 1263

Other funds holding KIDS

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lazard Asset Management's KIDS Position: Q1 2023 in Review

Lazard Asset Management sold out of OrthoPediatrics (KIDS) in Q1 2023, closing a stake of 2,127 shares — an estimated $84K sold.

Lazard Asset Management first reported a position in KIDS in Q3 2019 and held it in 7 quarters. The position peaked at $98K in Q3 2022. 122 funds tracked by Wall St. Rank hold KIDS as of Q1 2023.

  • Lazard Asset Management reported no remaining OrthoPediatrics position as of Q1 2023 after selling out during the quarter.
  • Lazard Asset Management sold 2,127 OrthoPediatrics shares in Q1 2023, an estimated $84K.
  • Lazard Asset Management first reported a position in OrthoPediatrics in Q3 2019 and held it in 7 quarters.
  • Lazard Asset Management's OrthoPediatrics position peaked at $98K in Q3 2022.
  • 122 funds tracked by Wall St. Rank held OrthoPediatrics as of Q1 2023.

Based on Lazard Asset Management's 13F filing for Q1 2023, filed 15 May 2023.